Novo Nordisk (NVO 2.62%) is struggling with competition from both compounders and larger rivals.
*Stock prices used were the afternoon prices of July 29, 2025. The video was published on July 31, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity?
By Parkev Tatevosian, CFA
–
Aug 2, 2025 at 9:00AM
NYSE: NVO
Novo Nordisk
Market Cap
$192B
Today's Change
(2.62%) $1.45
Current Price
$56.90
Price as of August 22, 2025, 3:58 p.m. ET
Competition from all sides is causing Novo Nordisk to revise its expectations for 2025.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Stocks Mentioned
Novo Nordisk
NVO
$56.90
(2.62%)
$1.45
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know
1 Reason to Buy NVO
Why Novo Nordisk Stock Popped Today
3 Undervalued Healthcare Stocks You Can Buy Now and Hold Long-Term
Why Novo Nordisk Stock Popped Monday
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.